Speaker
Prof. Karol Kaminski, Fanny Taborsak-Lines
When and where
Starts: Wednesday, 16 April 2025 - 11:00
Ends: Wednesday, 16 April 2025 - 12:00
Location:
Xtalks, Toronto, Canada
Location details: Free Registration on Xtalks.com
Event description
Glucose metabolism disturbances, particularly type 2 diabetes (T2D), are significant risk factors for cardiovascular disease. However, the biomarkers for atherosclerosis development in patients with T2D or prediabetes remain largely unexplored.
In this webinar, cardiovascular expert Prof. Karol Kaminski, MD, PhD, will present a study that contributes to closing this gap in research. This study identified proteomic biomarkers in individuals with untreated glucose metabolism disturbances who are not diagnosed with diabetes, chronic inflammatory, neoplastic, or cardiovascular disease.
Using the innovative Olink® Reveal kit, which measures approximately 1,000 low-abundance proteins in plasma across a wide range of biological pathways, numerous proteins have been identified that distinguish healthy controls from those with prediabetes and T2D.
Join this webinar to gain insights into how specific proteins can indicate more severe metabolic disorders and provide a better understanding of the pathogenesis of cardiovascular disease in diabetic patients.
Further details
IMPORTANT: In order to register to this free webinar you must register directly on Xtalks via the following URL: https://xtalks.com/webinars/uncovering-proteomic-biomarkers-linking-type-2-diabetes-to-cardiovascular-risk/
Geolocation will be visible after you sign in.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 44
- Comments 0